Erratum: Can RoTEM® analysis be applied for haemostatic monitoring in paediatric congenital heart surgery? Cardiology in the Young 2011 doi:10.1017/S1047951111000758.;Can RoTEM® analysis be applied for haemostatic monitoring in paediatric congenital heart surgery?

Cardiology in the Young

Volumn 21, Issue 6, 2011, Pages 684-691

  Andreasen, Jo Boønding ^a   Hvas, Anne Mette ^a   Christiansen, Kirsten ^a   Ravn, Hanne Berg ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bleeding; Children; coagulation; thromboelastometry

Indexed keywords

BLOOD CLOTTING FACTOR 13; D DIMER; FIBRIN; FIBRINOGEN; PROTHROMBIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; HEART SURGERY; HEMOSTASIS; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PREDICTIVE VALUE; PROTHROMBIN TIME; QUALITATIVE ANALYSIS; SCHOOL CHILD; SURGICAL TECHNIQUE; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOELASTOMETRY;

EID: 80155135733     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951113001947     Document Type: Erratum

References (23)

1. Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sorensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94: 324-329. (Pubitemid 40352852)
2. Chan AK, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77: 270-277. (Pubitemid 27084914)
3. Heimark RL, Kurachi K, Fujikawa K, Davie EW. Surface activation of blood coagulation, fibrinolysis and kinin formation. Nature 1980; 286: 456-460. (Pubitemid 10017679)
4. Williams GD, Bratton SL, Nielsen NJ, Ramamoorthy C. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1998; 12: 633-638. (Pubitemid 29001678)
5. Reed RL, Bracey Jr AW, Hudson JD, Miller TA, Fischer RP. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels. Circ Shock 1990; 32: 141-152. (Pubitemid 20386104)
6. Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1008-1014.
7. Slonim AD, Luban NL. Too much, too little, too soon, too late?. Transfusion and long-term survival in children. Transfusion 2008; 48: 796-798.
8. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43: 1684-1696.
9. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009; 24: 404-410.
10. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-57. (Pubitemid 36042031)
11. Royston D, von KS. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575-578. (Pubitemid 32266324)
12. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela- Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-319. (Pubitemid 29070189)
13. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002; 123: 110-118.
14. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007; 96: 644-647. (Pubitemid 46653167)
15. Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372.
16. Gorlinger K, Kong R, Nimmo A, Sorensen B. Recommendations for using the ROTEMs in the management of perioperative bleeding in Cardiac Surgery. In: Recommendations from the ROTEMs Expert Meeting Working Group, 2007.
17. Miller BE, Mochizuki T, Levy JH, et al. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997; 85: 1196-1202. (Pubitemid 28130510)
18. Blome M, Isgro F, Kiessling AH, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93: 1101-1107. (Pubitemid 40823515)
19. Gaarder C, Naess PA, Frischknecht CE, et al. Scandinavian Guidelines - ''The massively bleeding patient''. Scand J Surg 2008; 97: 15-36. (Pubitemid 351449961)
20. Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT. Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 2007; 105: 1610-1613. (Pubitemid 350190554)
21. Edwards RM, Naik-Mathuria BJ, Gay AN, Olutoye OO, Teruya J. Parameters of thromboelastography in healthy newborns. Am J Clin Pathol 2008; 130: 99-102.
22. Oswald E, Stalzer B, Heitz E, et al. Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth 2010; 105: 827-835.
23. Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008; 19: 212-219. (Pubitemid 351498725)